Ambulanzpartner Soziotechnologie APST GmbH

Industry / private company


Location: Berlin, Germany (DE) DE

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Correction to: Clinical characterization of common pathogenic variants of SOD1-ALS in Germany (Journal of Neurology, (2024), 271, 10, (6667-6679), 10.1007/s00415-024-12564-1) (2025) Wiesenfarth M, Forouhideh-Wiesenfarth Y, Elmas Z, Parlak Ö, Weiland U, Herrmann C, Schuster J, et al. Journal article, Erratum Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients (2024) Weishaupt JH, Körtvélyessy P, Schumann P, Valkadinov I, Weyen U, Hesebeck-Brinckmann J, Weishaupt K, et al. Journal article Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program (2024) Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak Ö, Uzelac Z, Kandler K, et al. Journal article Clinical characterization of common pathogenic variants of SOD1-ALS in Germany (2024) Wiesenfarth M, Forouhideh-Wiesenfarth Y, Elmas Z, Parlak Ö, Weiland U, Herrmann C, Schuster J, et al. Journal article Clinical and patient-reported outcomes and neurofilament response during tofersen treatment in SOD1-related ALS—A multicenter observational study over 18 months (2024) Meyer T, Schumann P, Weydt P, Petri S, Weishaupt JH, Weyen U, Koch JC, et al. Journal article